Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOPRELTO® and NUMBRINO™ in Pediatric Subjects
NCT04792034Phase 3Recruiting
- Sponsor
- LXO
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cocaine in nasal anesthesia (2 arms), sponsored by LXO. Primary endpoints: Changes in Blood pressure, Changes in Heart rate and 11 more. Started Dec 2025; status: recruiting.
02
Drugs
cocaine
03
Conditions
nasal anesthesia
Beyond the preview
Go deeper on NCT04792034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04792034.